eXoZymes, Inc.

NASDAQ:EXOZ

Biotechnology

Healthcare
$5.54 +16.75%

+$1.06 today

Market cap
$51.42M
Beta
2.66
P/E (TTM)
-6.5
EPS (TTM)
-$1.14
52W Low $6.33High $18.40

Volume 0.01M

Average 0.01M

EXOZ Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

eXoZymes, Inc.NASDAQ: EXOZ

Net Receivables · Q1 FY2026 · quarter ended Mar 2026

Net receivables falls 49.1% from a year ago

Net receivables stood at $302.86K at the end of Q1 FY2026, down 49.1% from a year earlier and down 41.5% from the prior quarter. Over 3 fiscal years it compounded at -13.9% a year.

Context

  • Net receivables amounted to 7.5% of total assets at the end of Q1 FY2026, up 2.4 pp from a year earlier.
  • Net receivables increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether net receivables keeps falling in the next quarterly balance sheet after a -49.1% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$302.86K-41.5% QoQ
Last fiscal yearDec 2025
$517.36K-29.8% YoY
Year agoMar 2025
$595.16K-49.1% since
Net Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-49.1%——
1 year-29.8%——
3-year CAGR-13.9%——
5-year CAGR——
10-year CAGR——

Net Receivables history

USD · from the balance sheet

Latest · FY2025
517.36K USD
Year-over-year change
-29.8%
4-year CAGR
+2.5%

Net Receivables vs competitors

How EXOZ compares with its peers on the latest reported figures

  • Peers report in different currencies, so net receivables is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -49.1% is the 5th highest of 6, against a peer median of +15.3%.
  • Net receivables amounts to 7.5% of total assets for EXOZ, versus a peer median of 7.1%.
EXOZ Competitors
Net Receivables for EXOZ and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
SRZNSurrozen, Inc.Mar 2026$5M USD+90.0%-52.8%4.1%
TLSATiziana Life Sciences LtdDec 2025$4.26M USD+15.3%-10.1%37.0%
CGTXCognition Therapeutics, Inc.Mar 2026$3.66M USD-23.5%+39.3%10.1%
ONCYOncolytics Biotech Inc.Mar 2026CA$961K CAD+979.8%+14.7%11.8%
EXOZeXoZymes, Inc.Mar 2026$302.86K USD-49.1%-13.9%7.5%
TILInstil Bio, Inc.Mar 2026$28K USD-97.0%—0.0%
GLSIGreenwich LifeSciences, Inc.Mar 2026$0 USD——0.0%
Peer median (excluding EXOZ) —+15.3%+2.3%7.1%

Competitors are the stored peer set for EXOZ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents547.81K558.57K66.53K9.72M3.04M
Short-term Investments00000
Net Receivables468.35K809.53K882.32K737.28K517.36K
Inventory00000
Other Current Assets30.19K101.14K264.76K363.79K382.89K
Total Current Assets1.05M1.47M1.21M10.82M3.94M
Property, Plant & Equipment (Net)1.3M1.22M2.34M2.21M2.21M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets0000(176.77K)
Total Non-current Assets1.3M1.22M2.34M2.21M2.03M
Total Assets2.35M2.69M3.56M13.03M5.97M
Account Payables267.3K385.8K702.91K924.25K1.24M
Short-term Debt00000
Tax Payables063.56K42.27K00
Deferred Revenue00000
Other Current Liabilities001M00
Total Current Liabilities400.78K634.36K2.42M1.33M1.57M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)161.11K215K140.7K00
Other Non-current Liabilities000123.58K90.37K
Total Non-current Liabilities748.25K678.77K1.53M1.28M1.01M
Total Liabilities1.15M1.31M3.94M2.61M2.57M
Common Stock126688
Retained Earnings(2.65M)(4.05M)(6.08M)(11.95M)(21.1M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity1.2M1.37M(384.32K)10.42M3.4M
Total Debt720.63K608.77K1.61M1.39M1.24M
Net Debt172.82K50.2K1.55M(8.33M)(1.8M)

eXoZymes, Inc.

NASDAQ:EXOZ

Intrinsic Alpha fair value

Locked

Current Price

$5.54

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.